Effects of encapsulation of microorganisms on product formation during microbial fermentations

被引:42
作者
Westman, Johan O. [1 ,2 ]
Ylitervo, Paeivi [1 ,2 ]
Franzen, Carl Johan [2 ]
Taherzadeh, Mohammad J. [1 ]
机构
[1] Univ Boras, Sch Engn, S-50190 Boras, Sweden
[2] Chalmers Univ Technol, S-41296 Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Encapsulation; Microbial cell; Whole-cell biocatalyst; Ethanol; Lactic acid; CELL MICROENCAPSULATION TECHNOLOGY; SACCHAROMYCES-CEREVISIAE; ALGINATE-CHITOSAN; CONTINUOUS CULTIVATION; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; ETHANOL-PRODUCTION; MAMMALIAN-CELL; CROSS-LINKING; MASS-TRANSFER;
D O I
10.1007/s00253-012-4517-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This paper reviews the latest developments in microbial products by encapsulated microorganisms in a liquid core surrounded by natural or synthetic membranes. Cells can be encapsulated in one or several steps using liquid droplet formation, pregel dissolving, coacervation, and interfacial polymerization. The use of encapsulated yeast and bacteria for fermentative production of ethanol, lactic acid, biogas, l-phenylacetylcarbinol, 1,3-propanediol, and riboflavin has been investigated. Encapsulated cells have furthermore been used for the biocatalytic conversion of chemicals. Fermentation, using encapsulated cells, offers various advantages compared to traditional cultivations, e.g., higher cell density, faster fermentation, improved tolerance of the cells to toxic media and high temperatures, and selective exclusion of toxic hydrophobic substances. However, mass transfer through the capsule membrane as well as the robustness of the capsules still challenge the utilization of encapsulated cells. The history and the current state of applying microbial encapsulation for production processes, along with the benefits and drawbacks concerning productivity and general physiology of the encapsulated cells, are discussed.
引用
收藏
页码:1441 / 1454
页数:14
相关论文
共 107 条
[31]   Alginate cell encapsulation: new advances in reproduction and cartilage regenerative medicine [J].
Ghidoni, Ilaria ;
Chlapanidas, Theodora ;
Bucco, Massimo ;
Crovato, Francesca ;
Marazzi, Mario ;
Vigo, Daniele ;
Torre, Maria Luisa ;
Faustini, Massimo .
CYTOTECHNOLOGY, 2008, 58 (01) :49-56
[32]   Bioencapsulation within synthetic polymers (Part 1): sol-gel encapsulated biologicals [J].
Gill, I ;
Ballesteros, A .
TRENDS IN BIOTECHNOLOGY, 2000, 18 (07) :282-296
[33]   OPTIMIZATION OF MICROENCAPSULATION PARAMETERS - SEMIPERMEABLE MICROCAPSULES AS A BIOARTIFICIAL PANCREAS [J].
GOOSEN, MFA ;
OSHEA, GM ;
GHARAPETIAN, HM ;
CHOU, S ;
SUN, AM .
BIOTECHNOLOGY AND BIOENGINEERING, 1985, 27 (02) :146-150
[34]  
Green KD, 1996, BIOTECHNOL BIOENG, V49, P535, DOI 10.1002/(SICI)1097-0290(19960305)49:5<535::AID-BIT6>3.0.CO
[35]  
2-K
[36]   MEMBRANE FORMATION BY INTERFACIAL CROSS-LINKING OF CHITOSAN FOR MICROENCAPSULATION OF LACTOCOCCUS-LACTIS [J].
GROBOILLOT, AF ;
CHAMPAGNE, CP ;
DARLING, GD ;
PONCELET, D ;
NEUFELD, RJ .
BIOTECHNOLOGY AND BIOENGINEERING, 1993, 42 (10) :1157-1163
[37]   POLY(ETHYLENIMINE)-REINFORCED LIQUID-CORE CAPSULES FOR THE CULTIVATION OF HYBRIDOMA CELLS [J].
HSU, YL ;
CHU, IM .
BIOTECHNOLOGY AND BIOENGINEERING, 1992, 40 (11) :1300-1308
[38]   Encapsulation of recombinant E. coli expressing cyclopentanone monooxygenase in polyelectrolyte complex capsules for Baeyer-Villiger biooxidation of 8-oxabicyclo[3.2.1]oct-6-en-3-one [J].
Hucik, Martin ;
Bucko, Marek ;
Gemeiner, Peter ;
Stefuca, Vladimir ;
Vikartovska, Alica ;
Mihovilovic, Marko D. ;
Rudroff, Florian ;
Iqbal, Naseem ;
Chorvat, Dusan, Jr. ;
Lacik, Igor .
BIOTECHNOLOGY LETTERS, 2010, 32 (05) :675-680
[39]   MICROENCAPSULATION OF LACTOCOCCUS-LACTIS WITHIN CROSS-LINKED GELATIN MEMBRANES [J].
HYNDMAN, CL ;
GROBOILLOT, AF ;
PONCELET, D ;
CHAMPAGNE, CP ;
NEUFELD, RJ .
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 1993, 56 (03) :259-263
[40]   Encapsulation of lactic acid bacteria with alginate/starch capsules [J].
Jankowski, T ;
Zielinska, M ;
Wysakowska, A .
BIOTECHNOLOGY TECHNIQUES, 1997, 11 (01) :31-34